Spontaneous remission of acute myeloid leukaemia after recovery from sepsis

Netherlands Journal of Medicine

Volumn 65, Issue 7, 2007, Pages 259-262

  Trof, R J ^a   Beishuizen, A ^a   Wondergem, M J ^a   Strack van Schijndel, R J M ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Acute myeloid leukaemia; Critically ill; Immune response; Mechanical ventilation; Sepsis; Spontaneous remission

Indexed keywords

ACICLOVIR; ANTINEOPLASTIC AGENT; CEFPIROME; CILASTATIN PLUS IMIPENEM; GANCICLOVIR; ITRACONAZOLE; VORICONAZOLE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; ARTIFICIAL VENTILATION; BONE MARROW BIOPSY; CANCER CHEMOTHERAPY; CASE REPORT; DISEASE SEVERITY; ERYTHROCYTE TRANSFUSION; HOSPITAL ADMISSION; HUMAN; INFECTION; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; LEUKOCYTOSIS; MALE; PANCYTOPENIA; PNEUMOTHORAX; RESPIRATORY FAILURE; SEPSIS; THROMBOCYTE TRANSFUSION;

ADULT; ANTI-BACTERIAL AGENTS; ANTINEOPLASTIC AGENTS; HUMANS; INTENSIVE CARE UNITS; IRAQ; LEUKEMIA, MYELOID, ACUTE; MALE; NETHERLANDS; PULMONARY VENTILATION; REMISSION, SPONTANEOUS; SEPSIS; TREATMENT OUTCOME;

EID: 34547797948     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Jabbour EJ, Estey E, Kantarjian HM. Adult acute myeloid leukaemia. Mayo Clin Proc 2006;81:247-60.
2. Depuydt PO, Benoit DD, Vandewoude KH, Decruyenaere JM, Colardyn FA. Outcome in noninvasively and invasively ventilated haematological patients with acute respiratory failure. Chest 2004;126:1299-306.
3. Cornet AD, Issa AI, van de Loosdrecht AA, Ossenkoppele GJ, Strack van Schijndel RJ, Groenveld AB. Sequential organ failure predicts mortality of patients with a haematological malignancy needing intensive care. Eur J Haematol 2005;74:511-6.
4. Eisenlohr C. Leuaemia lienalis: Lymphatic and medularis mit multiplen Gehirnnervenlähmungen. Vircows Arch A 1878;73:56-73.
5. Maywald O, Buchheidt D, Bergman J, Schoch C, et al. Spontaneous remission in adult acute myeloid leukemia in association with systemic bacterial infection - case report and review of the literature. Ann Hematol 2004;83:189-94.
6. Fozza C, Bellizzi S, Bonfigli S, et al. Cytogenetic and hematological spontaneous remission in a case of acute myelogenous leukemia. Eur J Haematol 2004;73:219-22.
7. Ifrah N, James JM, Viguie F, Marie JP, Zittoun R. Spontaneous remission in adult acute leukemia. Cancer 1985;56:1187-90.
8. Paul R, Remes K, Lakkala T, Pelliniemi TT. Spontaneous remission in acute myeloid leukemia. Br J Haematol 1994;86:210-2.
9. Müller CI, Trepel M, Kunzmann R, Lais A, et al. Hematologic and molecular spontaneous remission following sepsis in acute monoblastic leukemia with translocation (9;11): a case report and review of the literature. Eur J Haematol 2004;73:62-6.
10. Tzankov A, Ludescher C, Duba HC, et al. Spontaneous remission in a secondary acute myelogenous leukaemia following invasive pulmonary aspergillosis. Ann Hematol 2001;80:423-5.
11. Parillo JE. Pathogenetic mechanisms of septic shock. N Engl J Med 1993;328:1471-7.
12. Mitterbauer M, Fritzer-Szekeres M, Mitterbauer G, et al. Spontaneous remission of acute myeloid leukemia after infection and blood transfusion associated with hypergammaglobulinaemia. Ann Hematol 1996;73:189-93.
13. Jimenez C, Ribera JM, Abad E, et al. Increased serum tumour necrosis factor during transient remission in acute leukaemia. Lancet 1993;341:600.
14. Musto P, D'Arena G, Melillo L, et al. Spontaneous remission in acute myeloid leukaemia: a role for endogenous production of tumour necrosis factor and interleukin-2? Br J Haematol 1994;87:879-80.
15. Kolb HJ, Schattenberg A, Goldman JM, et al. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia. Blood 1995;86:2041-50.
16. Bergamaschi G, Cazzola M, Rosti V, et al. Tumor necrosis factor α modulates the messenger RNA expression of hematopoietic growth factor genes in fresh blast cells From patients with acute myeloblastic leukemia. Leukemia 1991;5:886-91.
17. Zhou BM, Findley HW, Ma L, et al. Effect of necrosis factor α on the proliferation of leukemia cells from children with B-cell precursor acute lymphoblastic leukemia (BCP-ALL): studies of primary leukemia cells and BCP-ALL cell lines. Blood 1991;77:2002-7.
18. Meloni G, Vignetti M, Andrizzi C, et al. Interleukin-2 for the treatment of advanced acute myelogenous leukemia patients with limited disease: updated experience with 20 cases. Leuk Lymphoma 1996;21:429-35.
19. Brune M, Castaigne S, Catalano J, et al. Improved leukemia-free survival after post-consolidation immunotherapy with histamine dihydrochloride and interleukin-2 in acute myeloid leukemia: results of a randomized phase III. Blood 2006;108:88-96.
20. Mackensen A, et al. Phase I study of adoptive T-cell therapy using antigen-specific CDS+ T cells for the treatment of patients with metastatic melanoma. J Clin Oncol 2006;24:5060-9.
21. Houtenbos I, Westers TM, Ossenkoppele GJ, van de Loosdrecht AA. Leukemia-derived dendritic cells: towards clinical vaccination protocols in acute myeloid leukemia. Haematologica 2006;91:348-55.